Isabelle Le Ber

9.5k total citations
51 papers, 1.8k citations indexed

About

Isabelle Le Ber is a scholar working on Neurology, Physiology and Molecular Biology. According to data from OpenAlex, Isabelle Le Ber has authored 51 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Neurology, 18 papers in Physiology and 13 papers in Molecular Biology. Recurrent topics in Isabelle Le Ber's work include Amyotrophic Lateral Sclerosis Research (33 papers), Alzheimer's disease research and treatments (17 papers) and Parkinson's Disease Mechanisms and Treatments (16 papers). Isabelle Le Ber is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (33 papers), Alzheimer's disease research and treatments (17 papers) and Parkinson's Disease Mechanisms and Treatments (16 papers). Isabelle Le Ber collaborates with scholars based in France, Italy and United States. Isabelle Le Ber's co-authors include Alexis Brice, Serena Lattante, Edor Kabashi, Agnès Camuzat, Sorana Ciura, Morwena Latouche, Didier Hannequin, Hervé Tostivint, François Salachas and Vincent Meininger and has published in prestigious journals such as Nature Neuroscience, Brain and Neurology.

In The Last Decade

Isabelle Le Ber

50 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabelle Le Ber France 22 1.3k 598 558 499 488 51 1.8k
Ilse Gijselinck Belgium 19 1.5k 1.1× 766 1.3× 616 1.1× 506 1.0× 852 1.7× 21 2.2k
Yongping Chen China 23 1.2k 0.9× 530 0.9× 463 0.8× 348 0.7× 252 0.5× 121 1.7k
Massimo Tortarolo Italy 25 1.0k 0.8× 753 1.3× 515 0.9× 324 0.6× 298 0.6× 42 1.8k
Serena Lattante Italy 23 1.2k 0.9× 771 1.3× 764 1.4× 422 0.8× 247 0.5× 54 1.8k
Michael A. Gitcho United States 14 1.1k 0.9× 530 0.9× 508 0.9× 286 0.6× 415 0.9× 21 1.4k
Elke Bogaert Belgium 16 1.5k 1.1× 1.0k 1.7× 798 1.4× 322 0.6× 383 0.8× 19 2.2k
Nicola J. Rutherford United States 25 1.9k 1.4× 560 0.9× 484 0.9× 671 1.3× 992 2.0× 38 2.4k
Noriko Fujimori-Tonou Japan 11 845 0.6× 515 0.9× 488 0.9× 430 0.9× 239 0.5× 16 1.4k
Parastoo Momeni United States 19 852 0.6× 534 0.9× 177 0.3× 320 0.6× 570 1.2× 37 1.5k
Marka van Blitterswijk United States 24 2.2k 1.6× 1.3k 2.2× 1.3k 2.3× 492 1.0× 414 0.8× 47 2.8k

Countries citing papers authored by Isabelle Le Ber

Since Specialization
Citations

This map shows the geographic impact of Isabelle Le Ber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Le Ber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Le Ber more than expected).

Fields of papers citing papers by Isabelle Le Ber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Le Ber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Le Ber. The network helps show where Isabelle Le Ber may publish in the future.

Co-authorship network of co-authors of Isabelle Le Ber

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Le Ber. A scholar is included among the top collaborators of Isabelle Le Ber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Le Ber. Isabelle Le Ber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Becker, E., Dario Saracino, Daisy Rinaldi, et al.. (2022). Disease Progression Score Estimation From Multimodal Imaging and MicroRNA Data Using Supervised Variational Autoencoders. IEEE Journal of Biomedical and Health Informatics. 26(12). 6024–6035. 10 indexed citations
2.
Gerrits, Emma, Lucia Giannini, Nieske Brouwer, et al.. (2022). Neurovascular dysfunction in GRN-associated frontotemporal dementia identified by single-nucleus RNA sequencing of human cerebral cortex. Nature Neuroscience. 25(8). 1034–1048. 43 indexed citations
3.
Batrancourt, Bénédicte, John S. H. Baxter, Isabelle Le Ber, et al.. (2022). An ecological approach to identify distinct neural correlates of disinhibition in frontotemporal dementia. NeuroImage Clinical. 35. 103079–103079. 4 indexed citations
4.
Ende, Emma L. van der, Estrella Morenas‐Rodríguez, Corey T. McMillan, et al.. (2021). CSF sTREM2 is elevated in a subset in GRN-related frontotemporal dementia. Neurobiology of Aging. 103. 158.e1–158.e5. 13 indexed citations
5.
Benussi, Alberto, Antonella Alberici, Kiran Samra, et al.. (2021). Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia. Alzheimer s & Dementia. 18(7). 1408–1423. 28 indexed citations
6.
Saracino, Dario, Vincent Huin, Fabienne Clot, et al.. (2020). Isolated parkinsonism is an atypical presentation of GRN and C9orf72 gene mutations. Parkinsonism & Related Disorders. 80. 73–81. 11 indexed citations
7.
Querin, Giorgia, Peter Bede, Mohamed Mounir El Mendili, et al.. (2019). Presymptomatic spinal cord pathology in c9orf72 mutation carriers: A longitudinal neuroimaging study. Annals of Neurology. 86(2). 158–167. 65 indexed citations
8.
Palencia-Madrid, Leire, Raquel Sánchez‐Valle, Oriol Grau‐Rivera, et al.. (2019). A unique common ancestor introduced P301L mutation in MAPT gene in frontotemporal dementia patients from Barcelona (Baix Llobregat, Spain). Neurobiology of Aging. 84. 236.e9–236.e15. 5 indexed citations
9.
Barbier, Mathieu, David Wallon, & Isabelle Le Ber. (2018). Monogenic inheritance in early-onset dementia: illustration in Alzheimer's disease and frontotemporal lobar dementia. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. 16(3). 289–297. 2 indexed citations
10.
Bartolomé, Fernando Benito, Noemí Esteras, Ángeles Martín‐Requero, et al.. (2017). Pathogenic p62/SQSTM1 mutations impair energy metabolism through limitation of mitochondrial substrates. Scientific Reports. 7(1). 1666–1666. 56 indexed citations
11.
Lattante, Serena, Hortense de Calbiac, Isabelle Le Ber, et al.. (2014). Sqstm1 knock-down causes a locomotor phenotype ameliorated by rapamycin in a zebrafish model of ALS/FTLD. Human Molecular Genetics. 24(6). 1682–1690. 67 indexed citations
12.
Millecamps, Stéphanie, Anne de Septenville, Elisa Teyssou, et al.. (2014). Genetic analysis of matrin 3 gene in French amyotrophic lateral sclerosis patients and frontotemporal lobar degeneration with amyotrophic lateral sclerosis patients. Neurobiology of Aging. 35(12). 2882.e13–2882.e15. 32 indexed citations
13.
Clot, Fabienne, Anne Rovelet‐Lecrux, Foudil Lamari, et al.. (2014). Partial deletions of the GRN gene are a cause of frontotemporal lobar degeneration. Neurogenetics. 15(2). 95–100. 7 indexed citations
14.
Ber, Isabelle Le, Gaël Nicolas, Agnès Camuzat, et al.. (2013). hnRNPA2B1 and hnRNPA1 mutations are rare in patients with “multisystem proteinopathy” and frontotemporal lobar degeneration phenotypes. Neurobiology of Aging. 35(4). 934.e5–934.e6. 51 indexed citations
15.
Ber, Isabelle Le. (2013). Genetics of frontotemporal lobar degeneration: An up-date and diagnosis algorithm. Revue Neurologique. 169(10). 811–819. 31 indexed citations
16.
Lattante, Serena, Isabelle Le Ber, Agnès Camuzat, Alexis Brice, & Edor Kabashi. (2012). Mutations in the PFN1 gene are not a common cause in patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration in France. Neurobiology of Aging. 34(6). 1709.e1–1709.e2. 21 indexed citations
17.
Camuzat, Agnès, Léna Guillot‐Noël, Nathalie Guy, et al.. (2010). FUS Mutations in Frontotemporal Lobar Degeneration with Amyotrophic Lateral Sclerosis. Journal of Alzheimer s Disease. 22(3). 765–769. 75 indexed citations
18.
Benajiba, Lina, Isabelle Le Ber, Agnès Camuzat, et al.. (2009). TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Annals of Neurology. 65(4). 470–473. 239 indexed citations
19.
Ber, Isabelle Le, Rose‐Marie Marié, Benoı̂t Chabot, Catherine Lalevée, & Gilles‐Louis Defer. (2007). Neuropsychological and 18FDG-PET studies in a family with idiopathic basal ganglia calcifications. Journal of the Neurological Sciences. 258(1-2). 115–122. 11 indexed citations
20.
Baba, Yasuhiko, Isabelle Le Ber, Alexis Brice, et al.. (2007). Clinical and genetic features of families with frontotemporal dementia and parkinsonism linked to chromosome 17 with a P301S tau mutation. Journal of Neural Transmission. 114(7). 947–950. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ilse Gijselinck Breakdown of academic impact, for papers by Yongping Chen Breakdown of academic impact, for papers by Massimo Tortarolo Breakdown of academic impact, for papers by Serena Lattante Breakdown of academic impact, for papers by Michael A. Gitcho Breakdown of academic impact, for papers by Elke Bogaert Breakdown of academic impact, for papers by Nicola J. Rutherford Breakdown of academic impact, for papers by Noriko Fujimori-Tonou Breakdown of academic impact, for papers by Parastoo Momeni Breakdown of academic impact, for papers by Marka van Blitterswijk
Rankless by CCL
2026